BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28167658)

  • 1. Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
    Campana D; Pui CH
    Blood; 2017 Apr; 129(14):1913-1918. PubMed ID: 28167658
    [No Abstract]   [Full Text] [Related]  

  • 2. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
    Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
    [No Abstract]   [Full Text] [Related]  

  • 4. Benign intracranial hypertension in association with acute lymphoblastic leukemia.
    Sastry J; Karandikar SS; English MW
    Pediatr Hematol Oncol; 2003 Mar; 20(2):157-60. PubMed ID: 12554527
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Attarbaschi A; Mann G; Zimmermann M; Bader P; Barisone E; Basso G; Biondi A; Cario G; Cazzaniga G; Colombini A; Flotho C; Kuhlen M; Lang P; Lauten M; Linderkamp C; Locatelli F; Lo Nigro L; Möricke A; Niggli F; Panzer-Grümayer R; Parasole R; Peters C; Caterina Putti M; Rizzari C; Suttorp M; Valsecchi MG; Conter V; Schrappe M;
    Leukemia; 2020 Jun; 34(6):1694-1700. PubMed ID: 31806872
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
    Fu RY; Liao QK; Jia CS
    Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):515-9. PubMed ID: 14746678
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
    Henze G; Fengler R; Reiter A; Ritter J; Riehm H
    Haematol Blood Transfus; 1990; 33():483-8. PubMed ID: 2182441
    [No Abstract]   [Full Text] [Related]  

  • 9. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.
    Pedrosa F; Coustan-Smith E; Zhou Y; Cheng C; Pedrosa A; Lins MM; Pedrosa M; Lucena-Silva N; Ramos AML; Vinhas E; Rivera GK; Campana D; Ribeiro RC
    Blood; 2020 Apr; 135(17):1458-1466. PubMed ID: 32027741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
    Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
    Sandoval C; Jayabose S
    Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
    Li C; Cai X; Chen X; Liang Y; Xia Z; Wang H
    Int J Hematol; 2019 Oct; 110(4):458-465. PubMed ID: 31321731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.
    Panzer-Grümayer ER; Schneider M; Panzer S; Fasching K; Gadner H
    Blood; 2000 Feb; 95(3):790-4. PubMed ID: 10648387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Bancillon A
    Arch Fr Pediatr; 1991 Oct; 48(8):593-4. PubMed ID: 1768205
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
    Bonney D; Razali H; Turner A; Will A
    Br J Haematol; 2009 Jun; 145(5):667-9. PubMed ID: 19344395
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
    Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M
    Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
    Raje N; Pai S; Vaidya S; Gopal R; Parikh P; Saikia T; Pai V; Nadkarni K; Advani IM
    Leuk Lymphoma; 1994 Jul; 14(3-4):285-90. PubMed ID: 7950917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.